💊
Rybelsus
semaglutide
Diabetes Mellitus, type 2
✅ Geautoriseerd
✅
Geen actieve meldingen
Dit geneesmiddel heeft geen lopende tekorten, veiligheidsbrieven of terugroepacties.
Waarvoor het wordt gebruikt
Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications in combination with other medicinal products for the treatment of diabetes. For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.
⚠️ Patiëntveiligheid
No
📚 Voorgaande meldingen (2)
Officiële EMA-pagina
https://www.ema.europa.eu/en/medicines/human/EPAR/rybelsus